{"id":"W2890512508","doi":"10.1200/jco.2018.36.15_suppl.8040","title":"Extended 5-y follow-up (FU) of phase 3 ELOQUENT-2 study of elotuzumab + lenalidomide/dexamethasone (ELd) vs Ld in relapsed/refractory multiple myeloma (RRMM).","year":2018,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Dalhousie University","funders":"","keywords":"Medicine; Lenalidomide; Internal medicine; Multiple myeloma; Dexamethasone; Oncology; Gastroenterology; Discontinuation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003025744,0.001006757,0.001804481,0.0003808229,0.000449534,0.0008920944,0.0007772453,0.00129513,0.004093943],"category_scores_gemma":[0.001485895,0.0004101273,0.001994087,0.0002961186,0.0004959501,0.001025717,0.0004331046,0.00261336,0.0006877781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008320292,"about_ca_system_score_gemma":0.0007659482,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007177725,"about_ca_topic_score_gemma":0.002786496,"domain_scores_codex":[0.9993178,0.0003907832,0.00002804734,0.00009409985,0.00005133926,0.0001179712],"domain_scores_gemma":[0.9990925,0.0002027586,0.0002479115,0.0000809765,0.00005671863,0.0003191064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9377055,0.007837396,0.006276324,0.0003435824,0.002314723,0.00009118503,0.0001149795,0.0008654844,0.004431697,0.00009214805,0.001866844,0.03806033],"study_design_scores_gemma":[0.5686128,0.3703416,0.05020244,0.0001070454,0.002806148,0.000245047,0.00006918851,0.001224112,0.001992543,0.0002999293,0.004064942,0.00003424067],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9880908,0.005236172,0.0005763556,0.0005190184,0.0001927335,0.001225253,0.002096006,0.00008987937,0.001973759],"genre_scores_gemma":[0.9915426,0.001205041,0.0006595038,0.0009054217,0.0001879658,0.0009342618,0.002302815,0.00001726283,0.002245091],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004093943,"threshold_uncertainty_score":0.01600182,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1717696052499525,"score_gpt":0.5024723600516399,"score_spread":0.3307027548016874,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}